Sensei Biotherapeutics Inc (SNSE)
0.5555
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.5438
-0.01
(-2.11%)
After-Hours: 20:00
Sensei Biotherapeutics Cash from Operations (Quarterly): -5.792M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -5.792M |
| March 31, 2024 | -7.616M |
| December 31, 2023 | -6.163M |
| September 30, 2023 | -4.661M |
| June 30, 2023 | -9.463M |
| March 31, 2023 | -11.74M |
| December 31, 2022 | -9.574M |
| September 30, 2022 | -6.803M |
| June 30, 2022 | -11.90M |
| Date | Value |
|---|---|
| March 31, 2022 | -10.75M |
| December 31, 2021 | -7.868M |
| September 30, 2021 | -5.577M |
| June 30, 2021 | -6.047M |
| March 31, 2021 | -10.77M |
| December 31, 2020 | -2.68M |
| September 30, 2020 | -5.798M |
| June 30, 2020 | -2.767M |
| March 31, 2020 | -6.46M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.90M
Minimum
Jun 2022
-2.68M
Maximum
Dec 2020
-7.357M
Average
-6.632M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 6.907M |
| Cash from Financing (Quarterly) | -0.18M |
| Free Cash Flow | -24.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2351 |
| Free Cash Flow Yield | -174.4% |